Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Rangering i aksjer #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Aksjekurs
$152.37
Markedsverdi
$376.33B
Endring (1 dag)
12.46%
Endring (1 år)
79.41%
Land
US
Handel Merck & Co., Inc. (MRK)

Kategori

Driftsmargin for Merck & Co., Inc. (MRK)
Driftsmargin per August 2026 TTM: 16.65%
Ifølge Merck & Co., Inc. sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 16.65%. Ved slutten av 2024 hadde selskapet en driftsmargin på 31.51%.
Historikk for driftsmargin for Merck & Co., Inc. fra 2000 til 2026
Driftsmargin ved slutten av hvert år
År Driftsmargin Endre
2026 (TTM) 16.65% -59.58%
2025 41.19% 30.72%
2024 31.51% 541.75%
2023 4.91% -84.08%
2022 30.84% 13.80%
2021 27.10% 102.84%
2020 13.36% -34.06%
2019 20.26% -4.07%
2018 21.12% 24.68%
2017 16.94% 22.66%
2016 13.81% -27.73%
2015 19.11% 20.80%
2014 15.82% -9.13%
2013 17.41% -16.70%
2012 20.90% 11.88%
2011 18.68% 155.89%
2010 7.30% -50.20%
2009 14.66% -42.53%
2008 25.51% 9.86%
2007 23.22% 42.54%
2006 16.29% -38.81%
2005 26.62% -9.52%
2004 29.42% -22.80%
2003 38.11% -10.08%
2002 42.38% -3.18%
2001 43.77% 94.36%
2000 22.52% 0.00%
Driftsmargin for lignende selskaper eller konkurrenter
Selskap Driftsmargin Forskjell i driftsmargin Land
43.92% -97.36%
US
26.81% -98.39%
US
29.32% -98.24%
US
26.59% -98.40%
CH
31.24% -98.12%
CH
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.